Details for New Drug Application (NDA): 211240
✉ Email this page to a colleague
The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 211240
Tradename: | CLOBETASOL PROPIONATE |
Applicant: | Quagen |
Ingredient: | clobetasol propionate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211240
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 211240
Suppliers and Packaging for NDA: 211240
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOBETASOL PROPIONATE | clobetasol propionate | SOLUTION;TOPICAL | 211240 | ANDA | Quagen Pharmaceuticals LLC | 70752-153 | 70752-153-04 | 1 BOTTLE in 1 CARTON (70752-153-04) / 50 mL in 1 BOTTLE |
CLOBETASOL PROPIONATE | clobetasol propionate | SOLUTION;TOPICAL | 211240 | ANDA | Quagen Pharmaceuticals LLC | 70752-153 | 70752-153-20 | 1 BOTTLE in 1 CARTON (70752-153-20) / 25 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Feb 17, 2022 | TE: | AT | RLD: | No |
Complete Access Available with Subscription